Startup Pointcare Genomics announced that it has been awarded a Small Business Innovation Research contract from the National Cancer Institute worth up to $2.3 million for the development of a technology designed to d..

Job-hopping makes you hard up for half year and job-diverting makes you hard up for three years. To those people who wants or yells to resign every day! 1. Don` t be quit from your team easily, otherwise you` ll s..

Insight Genetics has raised $3 million through a private securities offering, according to a filing with the US Securities and Exchange Commission. According to the filing, the Nashville, Tennessee-based company ..

At the annual meeting of the Association for Molecular Pathology this week, Illumina sponsored a panel in which leaders in the field discussed practical, reimbursement, and other considerations for labs implementing c..

Singapore General Hospital (SGH) and Thermo Fisher Scientific have announced a collaborative partnership that aims to identify cancer genetic mutations linked to Asian populations. The collaboration plans to u..

Recently，KHB signed the equity transfer agreement with the IBSA，Bouty，Altergon Italia and Mr.Cincotti. KHB agreed to contribute capital to establish the KHB Italy by KHB Hong Kong and Altergon Italia. KHB Hong Kong..

The National Cancer Institute announced that it plans to award $13 million in grant funding in fiscal year 2016 to support the establishment of up to 10 centers that will support the agency's Clinical Proteomic Tu..

Recently, Waters reported that its revenues in the third quarter were up 2 percent year over year, driven by broad-based demand in the life science markets. The company posted revenues of $500.6 million, and beati..

Epigenomics today announced that the US Food and Drug Administration has requested further data before making a decision on whether to approve the firm's blood-based colorectal cancer screening test. Epigenom..

The US Food and Drug Administration (FDA) have approved the first complementary diagnostic test to support use of OPDIVO (nivolumab) for non-squamous non-small-cell lung cancer (NSCLC) therapy. Historically, the o..

Recently，Nantong Egens Biotechnology Co., LTD. applied for listing on the new OTC market. Notice shows Weijun Ou, the president of Egens, holding 35.07% shares and Weiguo Ou, board director of Egens, holding 9.04% sh..

MDxHealth recently reported that its third quarter revenues increased 17 percent year over year, driven by sales of its ConfirmMDx for Prostate Cancer test. The Belgian molecular diagnostics firm reported total ..

PierianDx and Syapse are combining their respective products to provide an end-to-end genomic testing workflow for hospitals' pathology laboratories. The partners will integrate PierianDx's Clinical Genom..

Tute Genomics has acquired the assets of Knome for an undisclosed amount. Under the terms of the purchase agreement, Tute is integrating Knome's KnoSys technology with its cloud-based genome informatics and..

Infectious disease diagnostics firm DNAe today announced a bank facility of £25 million ($38.7 million) from Citibank, to fund the development of its point-of-care diagnostics for septic infections. The firm sai..

MacroGenics said today it has regained full global rights to the Phase I cancer compound enoblituzumab (MGA271), after Servier opted not to exercise its option to develop and commercialize the B7-H3-targeting monoclon..

Sigma-Aldrich said today it has acquired the Duolink® product portfolio from Olink Bioscience for an undisclosed price. The acquisition includes intellectual property, sales, marketing and manufacturing asset..

InDevR last week announced that it has received ISO 13485:2003 certification for the design, development, manufacture, and service of assays, instrumentation, and in vitro diagnostic devices. To obtain the certi..

Blood-testing start up Theranos, under fire after U.S. Food and Drug Administration inspectors found. Heavily redacted inspection reports were conducted Aug. 25 through Sept. 16, posted Oct.27 by the FDA, said Therano..

Igenica Biotherapeutics said recently it has launched an oncology research agreement with MedImmune to assess the potential of antibody-drug conjugates (ADCs) targeting surface antigen in leukemia (SAIL), a cell surfa..